Open Clinical Trials in Boston, Massachusetts
18 recruitingBoston, Massachusetts
Showing 1–18 of 18 trials
Recruiting
Phase 3
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Takeda171 enrolled112 locationsNCT06722235
Recruiting
Phase 2
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Immune Thrombocytopenia
Incyte Corporation56 enrolled40 locationsNCT07104565
Recruiting
Early Phase 1
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
Alzheimer DiseaseMild Cognitive ImpairmentLogopenic Progressive Aphasia+1 more
Massachusetts General Hospital30 enrolled1 locationNCT06538311
Recruiting
Phase 3
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
Open tíbia Fracture
University of Maryland, Baltimore312 enrolled34 locationsNCT05615844
Recruiting
Phase 3
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Takeda150 enrolled108 locationsNCT06948318
Recruiting
Phase 1
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Open-angle Glaucoma (OAG)NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Life Biosciences Inc.18 enrolled4 locationsNCT07290244
Recruiting
Early Phase 1
Early Intervention in High Risk CCUS
Clonal Cytopenia of Undetermined SignificanceCytopenia
Lachelle D. Weeks, MD, PhD108 enrolled1 locationNCT06802146
Recruiting
Phase 1
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Advanced Urothelial CarcinomaOral Drug AdministrationOpen Label
Flare Therapeutics Inc.120 enrolled12 locationsNCT05929235
Recruiting
Early Phase 1
Apixaban in Thrombocytopenia
ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting
Phase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Neutropenia
X4 Pharmaceuticals176 enrolled112 locationsNCT06056297
Recruiting
Phase 1
Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia
Osteopenia
Tufts Medical Center60 enrolled1 locationNCT07473713
Recruiting
Not Applicable
Neonatal Platelet Transfusion Threshold Trial
ThrombosisThrombocytopeniaNeonatal+4 more
NICHD Neonatal Research Network2,433 enrolled20 locationsNCT06676904
Recruiting
Not Applicable
A Trial of Hydrus Microstent Versus Goniotomy
GlaucomaGlaucoma, Open-Angle
Massachusetts Eye and Ear Infirmary243 enrolled1 locationNCT06289491
Recruiting
Phase 1Phase 2
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Open Angle GlaucomaOcular Hypertension
AbbVie96 enrolled49 locationsNCT04499248
Recruiting
Phase 4
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
NeutropeniaCytomegalovirus InfectionsInfection in Solid Organ Transplant Recipients+1 more
Tufts Medical Center25 enrolled1 locationNCT05626530
Recruiting
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
Immune Thrombocytopenia
Massachusetts General Hospital100 enrolled1 locationNCT06817395
Recruiting
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
BleedingNeonatal Thrombocytopenia
Karolinska Institutet250 enrolled8 locationsNCT04598750
Recruiting
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Neonatal Thrombocytopenia
Boston Children's Hospital160 enrolled2 locationsNCT03848923